Correlation Between Diffusion Pharmaceuticals and Avalo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diffusion Pharmaceuticals and Avalo Therapeutics, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Avalo Therapeutics.

Diversification Opportunities for Diffusion Pharmaceuticals and Avalo Therapeutics

-0.05

Correlation Coefficient

Diffusion Pharmaceuticals  Avalo Therapeutics

Good diversification

The 3 months correlation between Diffusion and Avalo is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Avalo Therapeutics go up and down completely randomly.

Pair Corralation between Diffusion Pharmaceuticals and Avalo Therapeutics

If you would invest  2,071  in Avalo Therapeutics on September 15, 2024 and sell it today you would lose (1,148) from holding Avalo Therapeutics or give up 55.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.37%
Values	Daily Returns

Diffusion Pharmaceuticals  vs.  Avalo Therapeutics

Diffusion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Avalo Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Avalo Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Avalo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Diffusion Pharmaceuticals and Avalo Therapeutics

The main advantage of trading using opposite Diffusion Pharmaceuticals and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.

The idea behind Diffusion Pharmaceuticals and Avalo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.